<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02880384</url>
  </required_header>
  <id_info>
    <org_study_id>16-172A</org_study_id>
    <nct_id>NCT02880384</nct_id>
  </id_info>
  <brief_title>Pathogen Detection and Community Acquired Pneumonia</brief_title>
  <official_title>Projected Influence of Enhanced Pathogen Detection on the Clinical Management of Community-Acquired Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Providence Health &amp; Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioFire Diagnostics, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Providence Health &amp; Services</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to compare the number of community-acquired pneumonia (CAP) pathogens detected using
      current diagnostic tests to the number detected using the BioFire Diagnostics investigational
      polymerase chain reaction (PCR) platform.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients diagnosed in the emergency department with CAP that requires hospitalization provide
      a sputum sample for culture and sensitivity testing, urine for detection of S. pneumonia and
      L. pneumophila, an anterior nasal swab for S. aureus PCR, a nasopharyngeal swab for S.
      pneumonia PCR and the FilmArray LRTI v.2.0 IUO Panel, and blood for procalcitonin testing
      and, in cases in which the patient is suffering rigors and hypotension, cultures. As part of
      this study, sputum or sputum equivalent will be acquired for testing using the FilmArray LRTI
      v.2.0 IUO Panel.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pathogen Detection</measure>
    <time_frame>5 Days</time_frame>
    <description>Compare the number of CAP pathogens detected using current diagnostic bundle to the number detected using the FilmArray LRTI v.2.0 IUO Panel.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment Influence</measure>
    <time_frame>5 Days</time_frame>
    <description>Determine the number of cases in which the FilmArray LRTI v.2.0 IUO Panel could allow for a switch from empiric to specific antimicrobial therapy if the results had been known by the healthcare provider.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasopharyngeal swabs compared to sputum</measure>
    <time_frame>5 Days</time_frame>
    <description>Compare the number of pathogens detected using an approved PCR panel using nasopharyngeal swabs to the number detected using the FilmArray LRTI v.2.0 IUO Panel.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Community Acquired Pneumonia</condition>
  <arm_group>
    <arm_group_label>FilmArray LRTI v.2.0 IUO Panel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will provide sputum or sputum equivalent for FilmArray LRTI v.2.0 IUO Panel testing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FilmArray LRTI v.2.0 IUO Panel</intervention_name>
    <description>Patients will provide sputum or sputum equivalent to be probed with FilmArray LRTI v.2.0 IUO Panelpanel.</description>
    <arm_group_label>FilmArray LRTI v.2.0 IUO Panel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Emergency Department physician diagnosis of CAP requiring hospitalization

        Exclusion Criteria:

          -  Inability to obtain sputum or sputum equivalent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Gilbert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence Health &amp; Services</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Gilbert, MD</last_name>
    <phone>(503) 294-2174</phone>
    <email>D.Gilbert@providence.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Portland Providence Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2016</study_first_submitted>
  <study_first_submitted_qc>August 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2016</study_first_posted>
  <last_update_submitted>August 17, 2017</last_update_submitted>
  <last_update_submitted_qc>August 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

